• Title/Summary/Keyword: transfusion

Search Result 557, Processing Time 0.028 seconds

Clinical Outcomes of Endoscopic Hemostasis for Bleeding in Patients with Unresectable Advanced Gastric Cancer

  • Song, In Ji;Kim, Hyun Ju;Lee, Ji Ae;Park, Jun Chul;Shin, Sung Kwan;Lee, Sang Kil;Lee, Yong Chan;Chung, Hyunsoo
    • Journal of Gastric Cancer
    • /
    • v.17 no.4
    • /
    • pp.374-383
    • /
    • 2017
  • Purpose: Bleeding is one of the most serious complications of advanced gastric cancer (AGC) and is associated with a poor prognosis. This study aimed to evaluate the clinical outcomes of endoscopic hemostasis for bleeding in patients with unresectable AGC. Materials and Methods: This study included 106 patients with bleeding associated with gastric cancer who had undergone endoscopic hemostasis between January 2010 and December 2013. Clinical characteristics, treatment outcomes, including rates of successful endoscopic hemostasis and rebleeding, risk factors for rebleeding, and overall survival (OS) were investigated. Results: Successful initial hemostasis was achieved in 83% of patients. Rebleeding occurred in 28.3% of patients within 30 days. The median OS after initial hemostasis was lower in patients with rebleeding than in those without rebleeding (2.7 and 3.9 months, respectively, P=0.02). There were no significant differences in disease status and rebleeding rates among patients with partial response or stable disease (n=4), progressive disease (n=64), and first diagnosis of disease (n=38). Univariate and multivariate analyses (P=0.038 and 0.034, respectively) revealed that transfusion of ${\geq}5$ units of RBCs was a significant risk factor for rebleeding. Conclusions: Despite favorable success rates of endoscopic hemostasis for bleeding associated with gastric cancer, the 30-day rebleeding rate was 28.3% and the median OS was significantly lower in patients with rebleeding than in those without rebleeding. Massive transfusion (${\geq}5$ units of RBCs) was the only significant risk factor for rebleeding. Patients with bleeding associated with AGC who have undergone massive transfusion should be observed closely following endoscopic hemostasis. Further research on approaches to reduce rebleeding rate and prevent death is needed.

Effect of Blood Donation on the Donor's Hemorheological Properties (헌혈이 헌혈자의 혈유변학적 지표에 미치는 영향)

  • Lee, Byoung Kwon
    • The Korean Journal of Blood Transfusion
    • /
    • v.29 no.3
    • /
    • pp.229-239
    • /
    • 2018
  • The circulatory system is closely related to the inter-relationship between the anatomy of the heart and blood vessels, and the fluid dynamic properties of blood. The physical properties of blood, which affect blood flow, are called hemorheologic factors. Hemorheologic factors, such as blood viscosity and erythrocyte aggregation, are influenced mainly by hematocrit. A higher hematocrit level results in an increase in blood viscosity, erythrocyte aggregation, which impedes the circulation itself, and tissue oxygenation. An excess of serum ferritin causes injury to vascular endothelial cells and erythrocytes via oxygen free radicals. In addition, an excess of blood can aggravatee the adverse effects of the hemorheologic parameters and induce atherogenesis, microcirculatory disturbances, and major cardiovascular events. A preventive and therapeutic approach with a phlebotomy or blood donation has been stimulated by the knowledge that blood loss, such as regular donations, is associated with significant decreases in key hemorheologic variables, including blood viscosity, erythrocyte aggregation, hematocrit, and fibrinogen. Major cardiovascular events have been improved in regular blood donors by improving blood flow and microcirculation by decreasing the level of oxidative stress, improving the hemorheologic parameters, and reducing the serum ferritin level. Confirmation of the positive preventive and therapeutic effects of blood donations on cardiovascular disease by a well-designed and well-controlled Cohort study may be good news to patients with cardiovascular disease or at risk of these diseases, as well as patients who require a transfusion.

Initial D-dimer level as early prognostic tool in blunt trauma patients without significant brain injury (중증 뇌손상이 없는 둔상 환자에서 초기 중증도 예측인자로서 D-dimer의 역할)

  • Sohn, Seok Woo;Lee, Jae Baek;Jin, Young Ho;Jeong, Tae Oh;Jo, Si On;Lee, Jeong Moon;Yoon, Jae Chol;Kim, So Eun
    • Journal of The Korean Society of Emergency Medicine
    • /
    • v.29 no.5
    • /
    • pp.430-436
    • /
    • 2018
  • Objective: The purpose of this study was to evaluate whether or not the d-dimer level indicating hyperfibrinolysis could be a predictor of early poor outcome (massive transfusion, death within 24 hours) associated with trauma-induced coagulopathy in blunt trauma without significant brain injury. Methods: This study was a retrospective observational study using 516 blunt trauma patients without significant brain injury. The poor outcome group, including patients receiving massive transfusion and those who died within 24 hours, consisted of 33 patients (6.4%). The variables were compared between the poor outcome group and good outcome group, and logistic regression analysis was performed using statistically significant variables. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the poor outcome prediction ability of the initial d-dimer level. Results: The poor outcome group showed more serious anatomical, physiological, and laboratory data than the good outcome group. In the ROC curve analysis for evaluation of the poor outcome prediction of the d-dimer level, the area under the curve value was 0.87 (95% confidence interval [CI], 0.84-0.90) while the cut-off value was 27.35 mg/L. In the logistic regression analysis, the high d-dimer level was shown to be an independent predictor of poor outcome (adjusted odds ratio, 14.87; 95% CI, 2.96-74.67). Conclusion: The high d-dimer level (>27.35 mg/L) can be used as a predictor for the poor outcome of patients with blunt trauma without significant brain injury.

Red Blood Cell Metabolism in Goats after Blood Transfusion (산양에서 수혈후의 적혈구 대사에 관하여)

  • Yu Chang Jun
    • Journal of the korean veterinary medical association
    • /
    • v.15 no.1112
    • /
    • pp.559-562
    • /
    • 1979
  • 산양에서 수혈후 적혈구과다증을 지속시킬 수 있는지 또 해당중간생산물들이 변하는 가에 관하여 연구한바 아래의 결론을 얻었다. 1. 산양의 상동적혈구는 순환혈액에서 곧 사라졌다. 이와 같은 현상은 수혈적혈구가 지속적으로 적혈구과다증을 일으킬 수 없다는 것을 시사한다. 2. 적혈구용적과 혈색소농도는 수혈후 유의성 있게 증가되었으나 해당중간생산물인 GSH 2,3-DPG 및 ATP는 유의성 있게 변하지 아니하였다.

  • PDF

Radiosterilization of Medical Products (전리방사선을 이용한 의료제품 멸균연구)

  • 민봉희;천기정;이강순
    • Korean Journal of Microbiology
    • /
    • v.11 no.4
    • /
    • pp.181-188
    • /
    • 1973
  • For the bulk sterilization, there are two traditional methods of autoclaving and exposure to ethylene oxide. However, autoclaving involves high temperatures and pressures and ethylene oxide is chemically highly reactive, so these methods are radiation, we have carried out sterility and safety tests on some medical products irradiated at varying radiation levels. The results obtained were as follows ; 1) The minimum dose of radiation for the sterilization of medical products was 2.5 Mrad. 2) The radiosterilization dose varied depending on the initial population of microorganisms. 3) In transfusion sets, a level of radiation of 2.5Mrad at room temperature produced no pyrogen and they remained bacteriologically sterile.

  • PDF

Delayed sternal closure (미연성 흉골 봉합치험 1)

  • An, Byeong-Hui;Lee, Dong-Jun
    • Journal of Chest Surgery
    • /
    • v.15 no.3
    • /
    • pp.308-310
    • /
    • 1982
  • During the closure of the sternum, following the mitral valve replacement for mitral stenoinsufficiency, hemodynamic instability with cardiac tamponade was developed. After transfusion of massive diuretics and albumin for a few times, reclosure of the sternum was attempted with development of hemodynamic instability. And so we decided delayed sternal closure. After 72 hours of mitral valve replacement, delayed sternal closure was done with success, and so we report this case with literatures.

  • PDF

Twins (쌍생아)

  • Lee, Oh-Kyung
    • Clinical and Experimental Pediatrics
    • /
    • v.48 no.7
    • /
    • pp.685-690
    • /
    • 2005
  • Recently, twinning rate increases in Korea since the early 1990s by delayed marriage and prevailing of assisted reproductive technology. But twin and higher-order multiples are at increased risk for perinatal and neonatal mortality over 5 fold despite of dramatic improvement of perinatal and neonatal care. Because twins are born more prematurely and have lower birth weights than singleton. In addition, twins are at increased risk for cerebral palsy mainly in monochorionic twins due to co-twin fetal death, twin to twin transfusion and congenital anomaly. So, this article reviews the factors contributing to the mortality and morbidity of the twins and the efforts to decrease the neonatal mortality of twins.

Neonatal jaundice (신생아 황달)

  • Lee, Sang Lak
    • Clinical and Experimental Pediatrics
    • /
    • v.49 no.1
    • /
    • pp.6-13
    • /
    • 2006
  • Jaundice is one of the most common gastrointestinal conditions found in neonatal period, and most jaundice is benign. But because of the possibility of bilirubin toxicity, every newborn infants must be examined to identify the development of severe hyperbilirubinemia. To prevent the development of severe hyperbilirubinemia, promote and support successful breast-feeding, perform a systemic assessment before discharge for the risk of severe hyperbilirubinemia, provide early and close follow-up program, and treat with phototherapy or exchange transfusion or other therapeutic modalities, if indicated, are recommended.

Cardiac Surgery of Jehovah`s Witness (여호와의 증인에 대한 개심술)

  • 나찬영
    • Journal of Chest Surgery
    • /
    • v.25 no.6
    • /
    • pp.645-649
    • /
    • 1992
  • Jehovah`s Witnesses who require cardiac operations represent a challenge to surgeon because of the patients` refusal to accept blood transfusion, We report a 6 year period, ending May, 1991 with a consecutive series of 25 Jehovah`s witnesses. Patients ranged in age from 11 months to 61 years. All operations were performed during cardiopulmonary bypass with bloodless priming, No patient received any blood or blood products during hospitalization. Perioperative mortality was 2 paients[8%]. We conclude that if we performed the cardiac surgery with careful operative technique and various blood conserving procedures, we can do the bloodless open heart surgery with relatively safety.

  • PDF